Shandong Weigao Group Medical Polymer Company Limited Goes Ex Dividend Monday
Lubomei has lowered the valuation of heavy stock holdings for the third time, why is it slower than other institutions? Public funds quickly withdraw from "zero return" stocks.
1. The reasons for the differences in valuation adjustments in public offerings may be related to the extent to which fund companies' products and their own funds hold positions in these stocks; 2. Recently, several fund companies have adjusted the valuations of stocks held by their funds, with some stock valuations adjusted to 0 yuan/share. These stocks have either been suspended for a long time, repeatedly hit the downward limit, or are on the brink of delisting.
How can the procurement brackets be used with peace of mind? Journalists investigate how the winning companies ensure "quality and supply guarantee" | Focus on the landing of centralized procurement ③
How did the winning companies adjust to the sudden price drop in brackets centralized procurement? How do they ensure the production quality of brackets with such a significant price difference? In their eyes, what are the optimization opportunities for centralized procurement?
Who's buying? The A-share market is closed, but the Hong Kong stock market is still going strong! There's a big shift in foreign capital underway.
According to the latest report published by Goldman Sachs, after the People's Bank of China announced easing measures and the September Political Bureau meeting, mainland consumer stocks rebounded strongly by an average of about 32% in the past week.
Hong Kong stock opportunity tracking | Hong Kong Exchange may suspend trading all day today; "Carrier-level" broker is coming! GTJA and Haitong Sec will merge and reorganize.
Nio Inc: In the second quarter, revenue increased by 98.9% year-on-year, and the loss narrowed significantly by 16.7% year-on-year; Greentown China's sales in the first 8 months exceeded 160 billion yuan; SHK PPT's profit dropped by approximately 20% in the last fiscal year.
The significant decline in performance is due to the price reduction of centrally purchased products. The chunli medical investment projects are generally delayed. | Directly hit the earnings conference.
Regarding the main reasons for the decline in revenue and net income, Chunli Medical stated that it was due to the impact of the implementation of the national high-value medical consumables volume-based procurement, which led to a decrease in the selling price of related products. Chunli Medical announced that, except for the replenishment project, the availability of the other four projects funded by the IPO has been adjusted with a delay.